Emergency Department Culture May Deter Medical Students From Selecting Specialty
By Lori Solomon HealthDay Reporter
WEDNESDAY, March 27, 2024 -- Emergency medicine (EM) culture may deter medical students from selecting the specialty, according to a study published online Feb. 9 in Academic Emergency Medicine Education and Training.
Rosemarie Diaz, M.D., from the University of California, Los Angeles, and colleagues examined how clinical experiences and perceptions of EM influence specialty selection by medical students, particularly women. Semistructured interviews were conducted with 25 senior medical students who considered EM as a specialty, from 11 geographically diverse schools.
The researchers identified four major themes. Students were negatively affected by distressing interpersonal interactions with patients and the emergency department care team. Behaviors that are perceived as exclusionary are part of EM culture. There was a gendered nature in the beliefs about the attributes of an ideal EM physician and the specialty itself. There was an increased interest based on ease of access to mentors, representation, and early exposure to EM.
"Our participants express that EM causes challenges for students to accept the norms of behavior in the field, which is an essential element in joining a group and professional identity formation," the authors write. "In addition, we raise concern that gendered perceptions and language may send exclusionary environmental cues that may negatively impact recruitment of a diverse physician workforce."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.